VP, Chief Medical Officer
• Executive with extensive experience in the pharmaceutical industry in privately owned and public, large multinational corporations and small biotechnology companies.
• Directed worldwide, Phase I-IV development programs in diverse therapeutic areas such as ophthalmology, pain/inflammatory conditions, psychiatry, oncology, rheumatology and gynecology.
• Acquired in-depth knowledge of the drug and device development process through direct personal accountability and interaction with U.S. and ex-U.S regulatory authorities.
• Established and directed multidisciplinary Clinical Development departments in three corporations resulting in US and ex-US NDA, BLA and PMA approvals.
• Authored numerous scientific articles in peer-reviewed journals.